These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29687929)

  • 1. A tale of two clones: Caldesmon staining in the differentiation of cutaneous spindle cell neoplasms.
    Beck EM; Bauman TM; Rosman IS
    J Cutan Pathol; 2018 Aug; 45(8):581-587. PubMed ID: 29687929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.
    Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S
    Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma.
    Sakamoto A; Oda Y; Yamamoto H; Oshiro Y; Miyajima K; Itakura E; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
    Virchows Arch; 2002 Apr; 440(4):404-9. PubMed ID: 11956822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. h-Caldesmon as a specific marker of smooth muscle cell differentiation in some soft tissue tumors of the skin.
    D'Addario SF; Morgan M; Talley L; Smoller BR
    J Cutan Pathol; 2002 Aug; 29(7):426-9. PubMed ID: 12139638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P75 nerve growth factor receptor as a useful marker to distinguish spindle cell melanoma from other spindle cell neoplasms of sun-damaged skin.
    Sigal AC; Keenan M; Lazova R
    Am J Dermatopathol; 2012 Apr; 34(2):145-50. PubMed ID: 22207443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
    Morgan MB; Purohit C; Anglin TR
    Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific but variable expression of h-caldesmon in leiomyosarcomas: an immunohistochemical reassessment of a novel myogenic marker.
    Hisaoka M; Wei-Qi S; Jian W; Morio T; Hashimoto H
    Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):302-8. PubMed ID: 11759055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors.
    Nucci MR; O'Connell JT; Huettner PC; Cviko A; Sun D; Quade BJ
    Am J Surg Pathol; 2001 Apr; 25(4):455-63. PubMed ID: 11257619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pleomorphic and dedifferentiated leiomyosarcoma: a clinicopathologic analysis].
    Sun M; Liu JG; Weng QY; Yu L; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):87-93. PubMed ID: 29429158
    [No Abstract]   [Full Text] [Related]  

  • 10. Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study.
    Ceballos KM; Nielsen GP; Selig MK; O'Connell JX
    Am J Clin Pathol; 2000 Nov; 114(5):746-53. PubMed ID: 11068549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. h-caldesmon immunoreactivity in atypical fibroxanthoma: implications for the differential diagnosis.
    Martinez-Ciarpaglini C; Agustí J; Alvarez E; Hueso L; Terrádez L; Monteagudo C
    Pathology; 2018 Apr; 50(3):358-361. PubMed ID: 29490873
    [No Abstract]   [Full Text] [Related]  

  • 12. In regard to "A tale of two clones: Caldesmon staining in the differentiation of cutaneous spindle-cell neoplasms".
    Martinez-Ciarpaglini C; Monteagudo C
    J Cutan Pathol; 2018 Nov; 45(11):869-870. PubMed ID: 30054907
    [No Abstract]   [Full Text] [Related]  

  • 13. Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases.
    Nicolas MM; Tamboli P; Gomez JA; Czerniak BA
    Hum Pathol; 2010 May; 41(5):663-71. PubMed ID: 20004935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Best practices in diagnostic immunohistochemistry: pleomorphic cutaneous spindle cell tumors.
    Folpe AL; Cooper K
    Arch Pathol Lab Med; 2007 Oct; 131(10):1517-24. PubMed ID: 17922587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spindle Cell Atypical Fibroxanthoma: Myofibroblastic Differentiation Represents a Diagnostic Pitfall in This Variant of AFX.
    Harding-Jackson N; Sangueza M; Mackinnon A; Suster S; Plaza JA
    Am J Dermatopathol; 2015 Jul; 37(7):509-14; quiz 515-6. PubMed ID: 26098709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma.
    Dotto JE; Glusac EJ
    J Cutan Pathol; 2006 Jun; 33(6):413-7. PubMed ID: 16776716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma.
    Wieland CN; Dyck R; Weenig RH; Comfere NI
    J Cutan Pathol; 2011 Nov; 38(11):884-8. PubMed ID: 21883368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFITM1, CD10, SMA, and h-caldesmon as a helpful combination in differential diagnosis between endometrial stromal tumor and cellular leiomyoma.
    Zhao W; Cui M; Zhang R; Shen X; Xiong X; Ji X; Tao L; Jia W; Pang L; Sun Z; Wang C; Zou H
    BMC Cancer; 2021 Sep; 21(1):1047. PubMed ID: 34556086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spindle cell neoplasm of skin: diagnostic dilemma.
    Jain M; Singh S; Agarwal K
    Indian J Pathol Microbiol; 2007 Oct; 50(4):814-6. PubMed ID: 18306566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma.
    Rush DS; Tan J; Baergen RN; Soslow RA
    Am J Surg Pathol; 2001 Feb; 25(2):253-8. PubMed ID: 11176075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.